Arcadia Biosciences (RKDA) Free Cash Flow (2016 - 2025)
Arcadia Biosciences' Free Cash Flow history spans 12 years, with the latest figure at -$861000.0 for Q4 2025.
- For Q4 2025, Free Cash Flow rose 60.54% year-over-year to -$861000.0; the TTM value through Dec 2025 reached -$4.7 million, up 50.72%, while the annual FY2025 figure was -$4.7 million, 50.72% up from the prior year.
- Free Cash Flow reached -$861000.0 in Q4 2025 per RKDA's latest filing, down from -$257000.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$257000.0 in Q3 2025 to a low of -$8.5 million in Q3 2021.
- Average Free Cash Flow over 5 years is -$3.5 million, with a median of -$3.3 million recorded in 2022.
- Peak YoY movement for Free Cash Flow: tumbled 72.6% in 2023, then soared 85.33% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$6.7 million in 2021, then surged by 64.36% to -$2.4 million in 2022, then crashed by 72.6% to -$4.2 million in 2023, then skyrocketed by 47.43% to -$2.2 million in 2024, then skyrocketed by 60.54% to -$861000.0 in 2025.
- Per Business Quant, the three most recent readings for RKDA's Free Cash Flow are -$861000.0 (Q4 2025), -$257000.0 (Q3 2025), and -$2.0 million (Q2 2025).